Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 EUR | -1.08% | -7.87% | +28.50% |
17/04 | OSE: licensing agreement with AbbVie enters into force | CF |
17/04 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- Other languages